News | Lung Imaging
Results from a prospective clinical trial showed a blood test looking at specific biomarkers was able to detect lung cancer recurrences an average of six months before conventional imaging methods found evidence of recurrence. In the largest prospective clinical trial to date of circulating tumor cells (CTC) as biomarkers for locally advanced lung cancer, the findings indicate that blood tests potentially can be used in conjunction with computed tomography (CT) and positron emission tomography (PET)/CT scans to guide personalized treatment planning for patients with non-small cell lung cancer (NSCLC). The study was presented at the 2017 Multidisciplinary Thoracic Cancers Symposium, March 16-18 in San Diego.
March 28, 2017 
News | Ultrasound Imaging
March 28, 2017 — Young rabbits exposed to ultrasound during fetal development had weaker thighbones than unexposed ...
March 28, 2017 
Technology | Computer-Aided Detection Software
March 27, 2017 — iCAD announced that PowerLook Tomo Detection received Premarket Approval (PMA) from the U.S. Food and ...
March 27, 2017 Sponsored Content
Sponsored Content
Videos | Radiology Business
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
November 11, 2025 Technology | Colonoscopy Systems
March 27, 2017 — Bracco Diagnostics Inc. announced the launch of its PROTOCO2L TOUCH Colon Insufflator. This device is ...
March 27, 2017 
News | Radiation Therapy
March 27, 2017 — Radiation therapists and physicians know that education can reduce anxiety before radiation treatment ...
March 27, 2017 
News | Proton Therapy
A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for curative treatment. In the largest analysis to date of re-irradiation using intensity-modulated proton therapy (IMPT) for lung and other thoracic tumors, more than three-fourths of patients were free from local recurrence at one year following retreatment, and fewer than one in ten patients experienced severe side effects. The study was presented at the 2017 Multidisciplinary Thoracic Cancers Symposium, March 14-16 in San Diego.
March 24, 2017 Sponsored Content
Feature | Breast Imaging
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
October 24, 2025 
Technology | Radiation Dose Management
Medsquare announced the integration of the organ dose module VirtualDose CT into its DACS (dose archive and communication system) Radiation Dose Monitor (RDM) solution. Developed in partnership with Virtual Phantoms Inc., this new module will be added to RDM’s existing features. It was presented for the first time at the European Congress of Radiology (ECR), March 1-5 in Vienna, Austria.
March 24, 2017 
News | Radiology Business | Jeff Zagoudis
March 24, 2017 — Facing the reality of not having enough votes to secure its passage, House leadership withdrew the ...
March 24, 2017 
News | Information Technology
Safe implementation of new technologies and therapies accompany classic patient safety challenges on ECRI Institute's “2017 Top 10 Patient Safety Concerns for Healthcare Organizations.” The report highlights concerns from health information management, clinical decision support and new oral anticoagulants, to long-standing concerns like test result reporting and follow-up and unrecognized patient deterioration.
March 24, 2017 Sponsored Content
Sponsored Content
Videos | Radiology Business
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
October 09, 2025 
News | Mammography
GE Healthcare announced the launch of its new Senographe Pristina mammography system, designed to make breast screening more comfortable and inviting for patients.
March 24, 2017 
News | Digital Radiography (DR)
Carestream announced that it provided a DRX Plus 3543 digital X-ray detector for the 2017 National Football League (NFL) Scouting Combine in Indianapolis to aid in physical examinations for top college football players. The detector was used with the existing X-ray system at Lucas Oil Stadium; additional tests were conducted at Indiana University Health Methodist Hospital in Indianapolis.
March 23, 2017 
News | Advanced Visualization
ContextVision recently received a patent approval on a new skeletal visualization technology for 3-D ultrasound.
March 23, 2017 Sponsored Content
Case Study | PACS
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
February 03, 2025 
News | Enterprise Imaging
March 23, 2017 — Swedish healthcare provider Danderyd Hospital AB has signed a five-year contract with Sectra for the ...
March 23, 2017 
News | Biopsy Systems
March 23, 2017 — Urology specialists at the Barbara Ann Karmanos Cancer Institute (Detroit) have begun using the UroNav ...
March 23, 2017 News | Prostate Cancer
Profound Medical Corp. announced that it has successfully completed the first sale of a TULSA-PRO system in Finland to the Turku University Hospital (“Tyks”). The deal was completed in collaboration with Philips, who is working in partnership with Profound to commercialize the TULSA-PRO system in Europe.
March 22, 2017 
News | Ultrasound Imaging
Carestream Health will show its Carestream Touch Prime and Touch Prime XE Ultrasound Systems at the American Institute of Ultrasound in Medicine convention, March 25-29 in Orlando, Fla. Both premium systems are designed for general diagnostic imaging use in radiology.
March 22, 2017 
News | Computed Tomography (CT)
Samsung NeuroLogica announced that its portable computed tomography (CT) technology will be included in Carolinas HealthCare System’s Levine Cancer Institute’s innovative Mobile Lung CT Unit. The unit will bring lung cancer diagnosis and intervention to underserved populations in the Carolinas.
March 22, 2017 
News | Lung Imaging
An emerging approach for cancer treatment seeks to combine radiation therapy with immune checkpoint inhibitors (ICPIs) to more effectively control tumors in the chest with an acceptable risk of severe treatment-related side effects. Ten percent of patients in a retrospective analysis of metastatic lung cancer experienced severe toxicity as a result of the combination therapy. Findings were presented at the 2017 Multidisciplinary Thoracic Cancers Symposium, March 16-18 in San Francisco.
March 22, 2017 
News | Computed Tomography (CT)
March 21, 2017 — Toshiba Medical demonstrated its Forward projected model-based Iterative Reconstruction SoluTion (FIRST ...
March 21, 2017 
A new imaging biomarker may help predict which children will take longer to recover from a traumatic brain injury (TBI), according to a preliminary study published online in Neurology.
March 21, 2017 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now